Partner Content
Harnessing the power of cell and gene therapy in oncology
By 2029, the global cell and gene therapy market is projected to be worth more than $81bn, according to GlobalData’s…
Harnessing artificial intelligence and digital technologies across the biopharma value chain
Artificial intelligence (AI) has the potential to revolutionize drug development through improved efficiency, accuracy, and speed. Research indicates biopharma companies…
The cutting-edge monitoring technology that is transforming the future of clinical trials
As the pharmaceutical landscape evolves, the complexity that these innovations require for their supply chains also increases. The development of…
Addressing key challenges in HPAPI manufacturing
HPAPIs offer crucial advantages in treatments for serious and complex diseases, such as cancer and autoimmune disorders. Designed to target…
Partnerships are key to driving digital healthcare transformation in US, say experts
Partnerships between different stakeholders in the healthcare industry are crucial for driving healthcare transformation. Stakeholders can include diverse groups –…
Can digital technology address US healthcare challenges?
The US healthcare system is facing several challenges, including rising costs, clinician shortages, and the need for improved efficiency and…
A proactive, data-driven approach to closing care gaps in heart disease
"Cardiovascular disease is preventable in many cases and early identification of risk is essential, especially for people at high risk," emphasizes…
Overcoming the added patient burden in DCTs
Decentralised clinical trials (DCTs) have long been heralded as the solution to many problems encountered in pharmaceutical research, most notably…
Gen AI and its use in medical devices and SaMD
Software as a Medical Device (SaMD) is software designed for medical purposes, providing additional capabilities and services to medical devices,…
Oncology in 2024: The clinical trial trends reshaping the role of CROs
Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated…